PTC’s Neutral Outlook: Strong Q4 Results Offset by Cautious FY2025 Guidance and Strategic Transition Challenges
Mizuho Securities analyst Siti Panigrahi has maintained their neutral stance on PTC stock, giving a Hold rating on October 31. Siti Panigrahi ...
PTC sees FY25 adjusted EPS $5.60-$6.30, consensus $5.83
PTC sees FY25 adjusted EPS $5.60-$6.30, consensus $5.83 Sees FY25 revenue $2.505B-$2.605B, consensus $2.54B. Published first on TheFly – the ultimate source for real-time, market-moving breaking ...
MarketWatch5d
PTC Therapeutics Inc.
Copyright © 2024 MarketWatch, Inc. All rights reserved.